Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail

Cardiovascular Institute, El Camino Hospital, Mountain View, California 94040.

OBJECTIVES. This study examined the predictors of in-hospital and 6-month outcome after different reperfusion strategies in acute myocardial infarction. BACKGROUND. Thrombolytic therapy and primary angioplasty are both widely applied as reperfusion modalities in patients with myocardial infarction. Although it is accepted that restoration of early patency of the infarct-related artery can reduce mortality and salvage myocardium, the optimal reperfusion strategy remains controversial, and the predictors of outcome in the reperfusion era have been incompletely characterized. METHODS. At 12 centers, 395 patients presenting within 12 h of onset of acute transmural myocardial infarction were prospectively randomized to receive tissue-type plasminogen activator (t-PA) or undergo primary angioplasty without antecedent thrombolysis. Sixteen clinical variables were examined with univariate and multiple logistic regression analysis to identify the predictors of clinical outcome. RESULTS. By univariate analysis, in-hospital mortality was increased in the elderly, women, patients with diabetes and in patients treated with t-PA as opposed to angioplasty. Only advanced age and treatment by t-PA versus angioplasty independently correlated with increased in-hospital mortality (6.5% vs. 2.6%, respectively, p = 0.039 by multiple logistic regression analysis). Similarly, the only variables independently related to in-hospital death or nonfatal reinfarction were advanced age and treatment by t-PA versus angioplasty (12.0% vs. 5.1%, p = 0.02). The reduction in in-hospital death or reinfarction with angioplasty versus t-PA was particularly marked in patients > or = 65 years of age (8.6% vs. 20.0%, p = 0.048). Furthermore, primary management with angioplasty versus t-PA was the most powerful multivariate correlate of freedom from recurrent ischemic events (10.3% vs. 28.0%, p = 0.0001). The independent beneficial effect of angioplasty on freedom from death or reinfarction was maintained at 6-month follow-up (8.2% vs. 17.0%, p = 0.02). CONCLUSIONS. In the reperfusion era, the two most powerful determinants of freedom from death, reinfarction and recurrent ischemia after myocardial infarction are young age and treatment by primary angioplasty.

This article has been cited by other articles:

				K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al. Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology Circulation, May 15, 2007; 115(19): 2570 - 2589. [Abstract] [Full Text] [PDF]

				Y. Numaguchi, T. Sone, K. Okumura, M. Ishii, Y. Morita, R. Kubota, K. Yokouchi, H. Imai, M. Harada, H. Osanai, et al. The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction Circulation, July 4, 2006; 114(1_suppl): I-114 - I-119. [Abstract] [Full Text] [PDF]

				M. Stramba-Badiale, K. M. Fox, S. G. Priori, P. Collins, C. Daly, I. Graham, B. Jonsson, K. Schenck-Gustafsson, and M. Tendera Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology Eur. Heart J., April 2, 2006; 27(8): 994 - 1005. [Abstract] [Full Text] [PDF]

				K D Dawkins, T Gershlick, M de Belder, A Chauhan, G Venn, P Schofield, D Smith, J Watkins, H H Gray, and Joint Working Group on Percutaneous Coronary Inter Percutaneous coronary intervention: recommendations for good practice and training Heart, December 1, 2005; 91(suppl_6): vi1 - vi27. [Abstract] [Full Text] [PDF]

				A. K. Bilge, Y. Nisanci, E. Yilmaz, B. Ozben, A. Oncul, F. Mercanoglu, and M. Meric Effects of Percutaneous Coronary Thrombectomywith the X-Sizer Catheter on Epicardial Flow and Microvascular Function in Acute Coronary Syndromes Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 461 - 466. [Abstract] [PDF]

				K. Huber, R. D. Caterina, S. D. Kristensen, F. W.A. Verheugt, G. Montalescot, L. B. Maestro, F. V. d. Werf, and for the Task Force on Pre-hospital Reperfusion The Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 2063 - 2074. [Full Text] [PDF]

				Z. Huczek, J. Kochman, K. J. Filipiak, G. J. Horszczaruk, M. Grabowski, R. Piatkowski, J. Wilczynska, A. Zielinski, B. Meier, and G. Opolski Mean Platelet Volume on Admission Predicts Impaired Reperfusion and Long-Term Mortality in Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention J. Am. Coll. Cardiol., July 19, 2005; 46(2): 284 - 290. [Abstract] [Full Text] [PDF]

				P M Schofield Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention Heart, June 1, 2005; 91(suppl_3): iii7 - iii11. [Full Text] [PDF]

				M. W. Krucoff, P. Johanson, R. Baeza, S. W. Crater, and M. Dellborg Clinical Utility of Serial and Continuous ST-Segment Recovery Assessment in Patients With Acute ST-Elevation Myocardial Infarction: Assessing the Dynamics of Epicardial and Myocardial Reperfusion Circulation, December 21, 2004; 110(25): e533 - e539. [Full Text] [PDF]

				C. O. Costantini, G. W. Stone, R. Mehran, E. Aymong, C. L. Grines, D. A. Cox, T. Stuckey, M. Turco, B. J. Gersh, J. E. Tcheng, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J. Am. Coll. Cardiol., July 21, 2004; 44(2): 305 - 312. [Abstract] [Full Text] [PDF]

				C.-I Cheng, K.-H. Yeh, H.-W. Chang, T.-H. Yu, Y.-H. Chen, H.-T. Chai, and H.-K. Yip Comparison of Baseline Characteristics, Clinical Features, Angiographic Results, and Early Outcomes in Men vs Women With Acute Myocardial Infarction Undergoing Primary Coronary Intervention Chest, July 1, 2004; 126(1): 47 - 53. [Abstract] [Full Text] [PDF]

				S. F. Yan, R. Ramasamy, Y. Naka, and A. M. Schmidt Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond Circ. Res., December 12, 2003; 93(12): 1159 - 1169. [Abstract] [Full Text] [PDF]

				H. M. Sadeghi, G. W. Stone, C. L. Grines, R. Mehran, S. R. Dixon, A. J. Lansky, M. Fahy, D. A. Cox, E. Garcia, J. E. Tcheng, et al. Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction Circulation, December 2, 2003; 108(22): 2769 - 2775. [Abstract] [Full Text] [PDF]

				H.-K. Yip, C.-J. Wu, H.-W. Chang, Y.-K. Hsieh, C.-Y. Fang, S.-M. Chen, and M.-C. Chen Impact of Tirofiban on Angiographic Morphologic Features of High-Burden Thrombus Formation During Direct Percutaneous Coronary Intervention and Short-term Outcomes Chest, September 1, 2003; 124(3): 962 - 968. [Abstract] [Full Text] [PDF]

				H.-K. Yip, C.-J. Wu, M. Fu, K.-H. Yeh, T.-H. Yu, W.-C. Hung, and M.-C. Chen Clinical Features and Outcome of Patients With Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction Resulting From Left Circumflex Artery Occlusion Chest, December 1, 2002; 122(6): 2068 - 2074. [Abstract] [Full Text] [PDF]

				H.-K. Yip, M.-C. Chen, H.-W. Chang, C.-L. Hang, Y.-K. Hsieh, C.-Y. Fang, and C.-J. Wu Angiographic Morphologic Features of Infarct-Related Arteries and Timely Reperfusion in Acute Myocardial Infarction: Predictors of Slow-Flow and No-Reflow Phenomenon Chest, October 1, 2002; 122(4): 1322 - 1332. [Abstract] [Full Text] [PDF]

				H.-K. Yip, C.-J. Wu, M.-C. Chen, H.-W. Chang, K. Y.-K. Hsieh, C.-L. Hang, and M. Fu Effect of Primary Angioplasty on Total or Subtotal Left Main Occlusion : Analysis of Incidence, Clinical Features, Outcomes, and Prognostic Determinants Chest, October 1, 2001; 120(4): 1212 - 1217. [Abstract] [Full Text] [PDF]

				S. Hamada, T. Nishiue, S. Nakamura, T. Sugiura, H. Kamihata, H. Miyoshi, Y. Imuro, and T. Iwasaka TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction J. Am. Coll. Cardiol., September 1, 2001; 38(3): 666 - 671. [Abstract] [Full Text] [PDF]

				G. W. Stone, D. Cox, E. Garcia, B. R. Brodie, M.-C. Morice, J. Griffin, L. Mattos, A. J. Lansky, W. W. O'Neill, and C. L. Grines Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials Circulation, August 7, 2001; 104(6): 636 - 641. [Abstract] [Full Text] [PDF]

				R. Ramasamy, J. A. Payne, J. Whang, S. R. Bergmann, and S. Schaefer Protection of ischemic myocardium in diabetics by inhibition of electroneutral Na+-K+-2Cl{-} cotransporter Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H515 - H522. [Abstract] [Full Text] [PDF]

				C. Rickers, K. Sasse, R. Buchert, H. Stern, J.o. van den Hoff, M. Lubeck, and J. Weil Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1676 - 1683. [Abstract] [Full Text] [PDF]

				D. M. Shindler, S. T. Palmeri, T. A. Antonelli, L. A. Sleeper, J. Boland, T. P. Cocke, J. S. Hochman, and for the SHOCK Investigators Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1097 - 1103. [Abstract] [Full Text] [PDF]

				T. Akasaka, K. Yoshida, T. Kawamoto, S. Kaji, Y. Ueda, A. Yamamuro, T. Takagi, and T. Hozumi Relation of Phasic Coronary Flow Velocity Characteristics With TIMI Perfusion Grade and Myocardial Recovery After Primary Percutaneous Transluminal Coronary Angioplasty and Rescue Stenting Circulation, May 23, 2000; 101(20): 2361 - 2367. [Abstract] [Full Text] [PDF]

				J. Z. Ayanian and E. Braunwald Thrombolytic Therapy for Patients With Myocardial Infarction Who Are Older Than 75 Years : Do the Risks Outweigh the Benefits? Circulation, May 16, 2000; 101(19): 2224 - 2226. [Full Text] [PDF]

				R. Yuval, D. A. Halon, A. Merdler, N. Khader, B. Karkabi, K. Uziel, and B. S. Lewis Patient Comprehension and Reaction to Participating in a Double-blind Randomized Clinical Trial (ISIS-4) in Acute Myocardial Infarction Arch Intern Med, April 24, 2000; 160(8): 1142 - 1146. [Abstract] [Full Text] [PDF]

				T. Nakabayashi, T. Hayashi, Y. Inoue, A. Ikeda, H. Morii, N. Naito, K. Ishikawa, and K. Kanamasa Percutaneous Transluminal Coronary Angioplasty Performed 24-48 Hours After the Onset of Acute Myocardial Infarction Improves Chronic-Phase Left Ventricular Regional Wall Motion Angiology, April 1, 2000; 51(4): 281 - 288. [Abstract] [PDF]

				S. Gottlieb, V. Boyko, D. Harpaz, H. Hod, M. Cohen, L. Mandelzweig, Z. Khoury, S. Stern, S. Behar, and for the Israeli Thrombolytic Survey Group Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction J. Am. Coll. Cardiol., July 1, 1999; 34(1): 70 - 82. [Abstract] [Full Text] [PDF]

				G. W. Stone, B. R. Brodie, J. J. Griffin, C. Costantini, M. C. Morice, F. G. St. Goar, P. A. Overlie, J. J. Popma, J. McDonnell, D. Jones, et al. Clinical and Angiographic Follow-Up After Primary Stenting in Acute Myocardial Infarction : The Primary Angioplasty in Myocardial Infarction (PAMI) Stent Pilot Trial Circulation, March 30, 1999; 99(12): 1548 - 1554. [Abstract] [Full Text] [PDF]

				W. J. Rogers Jr, C. M. Kramer, G. Geskin, Y.-L. Hu, T. M. Theobald, D. A. Vido, S. Petruolo, and N. Reichek Early Contrast-Enhanced MRI Predicts Late Functional Recovery After Reperfused Myocardial Infarction Circulation, February 16, 1999; 99(6): 744 - 750. [Abstract] [Full Text] [PDF]

				D. R. Holmes Jr., H. D. White, K. S. Pieper, S. G. Ellis, R. M. Califf, and E. J. Topol Effect of age on outcome with primary angioplasty versus thrombolysis J. Am. Coll. Cardiol., February 1, 1999; 33(2): 412 - 419. [Abstract] [Full Text] [PDF]

				M. A. Rowland, P. Nagley, A. W. Linnane, and F. L. Rosenfeldt Coenzyme Q10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat Cardiovasc Res, October 1, 1998; 40(1): 165 - 173. [Abstract] [Full Text] [PDF]

				N. Aoki and H. Tomoda Plasma Soluble P-Selectin in Acute Myocardial Infarction: Effects of Coronary Recanalization Therapy Angiology, September 1, 1998; 49(9): 807 - 813. [Abstract] [PDF]

				J. Z. Ayanian, M. B. Landrum, S.-L. T. Normand, E. Guadagnoli, and B. J. McNeil Rating the Appropriateness of Coronary Angiography -- Do Practicing Physicians Agree with an Expert Panel and with Each Other? N. Engl. J. Med., June 25, 1998; 338(26): 1896 - 1904. [Abstract] [Full Text] [PDF]

				A H Gershlick and R S More Recent advances: Treatment of myocardial infarction BMJ, January 24, 1998; 316(7127): 280 - 284. [Full Text]

				The Global Use of Strategies to Open Occluded Coro A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial Infarction N. Engl. J. Med., June 5, 1997; 336(23): 1621 - 1628. [Abstract] [Full Text] [PDF]

				S. Gottlieb, U. Goldbourt, V. Boyko, G. Barbash, L. Mandelzweig, H. Reicher-Reiss, S. Stern, and S. Behar Improved Outcome of Elderly Patients (>=75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel Circulation, January 21, 1997; 95(2): 342 - 350. [Abstract] [Full Text]

				R. A. Lange, L. D. Hillis, C. L. Grines, R. A. Lange, L. D. Hillis, and C. L. Grines Should Thrombolysis or Primary Angioplasty Be the Treatment of Choice for Acute Myocardial Infarction? N. Engl. J. Med., October 24, 1996; 335(17): 1311 - 1312. [Full Text] [PDF]

				Outcomes Compared for Angioplasty vs. t-PA for MI Journal Watch Cardiology, March 1, 1995; 1995(301): 11 - 11. [Full Text]